PUT SPRINTER OPEN END - ROCHE GS Share Price

Certificat

OROADV

CH1197331908

Real-time Bid/Ask 11:50:38 07/06/2024 BST
1.03 CHF / 1.04 CHF -3.27% Intraday chart for PUT SPRINTER OPEN END - ROCHE GS
Current month-5.31%
1 month-15.75%
Date Price Change
06/06/24 1.07 -1.83%
05/06/24 1.09 -1.80%
04/06/24 1.11 -1.77%
31/05/24 1.13 -2.59%
30/05/24 1.16 +0.87%

Delayed Quote Swiss Exchange

Last update June 06, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
OROADV
ISINCH1197331908
Date issued 14/07/2022
Strike 343.2 CHF
Maturity Unlimited
Parity 100 : 1
Emission price 0.6 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 1.32 CHF
Lowest since issue 0.46 CHF
Spread 0.01 CHF
Spread %0.96%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
238.1 CHF
Average target price
277.5 CHF
Spread / Average Target
+16.56%
Consensus
  1. Stock Market
  2. Certificates
  3. OROADV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW